Acclaimed training program begins April 18, 2017

Tufts CTSI will host Pfizer’s acclaimed Investigator Training Program (iTP) on April 18-19, 2017.

This unique, two-day, free-of-charge program will empower clinicians to build critical skills required for the recruitment, management, conduct, and reporting of clinical trials. It will examine the entire trial process, from planning stages to trial close-out activities, and will provide practical recommendations for increasing the efficiency of clinical trial conduct at investigative sites.

Led by clinical trial experts, this interactive training will consist of didactic lectures, discussions, and group activities. The iTP is targeted to investigators and the entire clinical study team, including research fellows, coordinators, research nurses, data managers, regulatory, and IRB members. Clinical trial experience (even if limited) is encouraged, though not required.

Attendees will receive a certificate of attendance after completing this International Conference on Harmonisation (ICH)/Good Clinical Practice (GCP) program. This workshop is approved for 16.5 contact hours towards maintaining an Association of Clinical Research Professionals (ACRP) certification. Contact hours are applicable to CCRCs, CCRAs and CPIs at an entry-level knowledge base.

This is a popular training, and class size is limited, so please pre-register by no later than April 7. You will receive an official email invitation from Pfizer if you are admitted to the program.

Please note: registration is a two-step process. Once you pre-register with Tufts CTSI, you will receive a formal registration form from Pfizer. You must be registered with Pfizer in order to attend this training and receive certification.

Details

Tuesday, April 18, 7:30AM-5:00PM
Wednesday, April 19, 8:30AM-3:30PM
Registration and continental breakfast begin at 8:00AM.

Arthur M. Sackler Center for Medical Education, Room 114
145 Harrison Avenue, Boston MA

Contact

Questions? Please email info@tuftsctsi.org for assistance.